ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.
about
Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapyIntegrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancerOverview of a chemoresponse assay in ovarian cancerDiscoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression.Gallotannin imposes S phase arrest in breast cancer cells and suppresses the growth of triple-negative tumors in vivo.Lysosomal trafficking of TGFBIp via caveolae-mediated endocytosis.ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells.Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma.SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells.Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell linesHigh-level β1-integrin expression in a subpopulation of highly tumorigenic oral cancer cells.A Decision Tree Based Classifier to Analyze Human Ovarian Cancer cDNA Microarray Datasets.
P2860
Q26768521-2DDD27B9-4046-4310-8F6D-DCE1B23629FAQ28484592-588FC56B-11A5-4AED-8633-20685C9C5783Q34071625-12B3F59D-E4CB-46A5-80C8-A47039CC1E7AQ34450477-A0055D4A-8F7B-4DF8-BC03-9154D55C267DQ35128160-5BF46776-6FB8-4157-975F-82C2B2E66160Q35326895-ED667A76-9323-49D3-99D9-0D981FCDE2ECQ35691781-4251C97E-1754-48DB-A72E-19E220A81170Q35888797-527FEA72-7158-4F76-9138-45C2C1F34450Q36131297-286E04EC-07B7-49EF-9FE2-33F8E6D847C7Q36202508-8CBD42BD-6AA9-4D2A-9A84-D4C3C8CF49B5Q36782342-F316EBF7-1228-44E9-86FD-3F0EF188E4F7Q37040599-EC2C0130-3B35-4A43-8E81-E6735E240C55Q38311815-58F39B2C-66BB-4D85-A216-B3953BEC233AQ38654867-1422C1E1-B082-4B79-AAD7-3F4F4EC54717Q38700421-6280D2B2-7324-44DA-87EA-C8189C9D5AAAQ46413521-08EA8D65-32B6-4360-BA64-B6BEC87471EFQ50780244-11CE99D9-919F-459A-A395-115223B6EBDE
P2860
ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
ß3 integrin modulates transfor ...... ponse in ovarian cancer cells.
@ast
ß3 integrin modulates transfor ...... ponse in ovarian cancer cells.
@en
type
label
ß3 integrin modulates transfor ...... ponse in ovarian cancer cells.
@ast
ß3 integrin modulates transfor ...... ponse in ovarian cancer cells.
@en
prefLabel
ß3 integrin modulates transfor ...... ponse in ovarian cancer cells.
@ast
ß3 integrin modulates transfor ...... ponse in ovarian cancer cells.
@en
P2860
P356
P1433
P1476
ß3 integrin modulates transfor ...... sponse in ovarian cancer cells
@en
P2093
Jillian Temple
P2860
P2888
P356
10.1186/1476-4598-11-36
P577
2012-05-28T00:00:00Z
P5875
P6179
1003097100